These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 8151775)

  • 1. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.
    Martarano L; Stephens R; Rice N; Derse D
    J Virol; 1994 May; 68(5):3102-11. PubMed ID: 8151775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
    Liao HJ; Baker CC; Princler GL; Derse D
    Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.
    Belshan M; Park GS; Bilodeau P; Stoltzfus CM; Carpenter S
    Mol Cell Biol; 2000 May; 20(10):3550-7. PubMed ID: 10779344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing.
    Gontarek RR; Derse D
    Mol Cell Biol; 1996 May; 16(5):2325-31. PubMed ID: 8628299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
    Chung H ; Derse D
    J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
    Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
    J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs.
    Princler GL; Julias JG; Hughes SH; Derse D
    Virology; 2003 Dec; 317(1):136-45. PubMed ID: 14675632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.
    Zhang X; Li J; Zhang M; Bai B; Ma W; Lin Y; Guo X; Wang XF; Wang X
    J Virol; 2022 Sep; 96(18):e0098622. PubMed ID: 36069548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs.
    Szilvay AM; Bøe SO; Kalland KH
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():1965-1974. PubMed ID: 10466792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and biological characterization of equine infectious anemia virus Rev.
    Carpenter S; Dobbs D
    Curr HIV Res; 2010 Jan; 8(1):87-93. PubMed ID: 20210784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections.
    Rasty S; Dhruva BR; Schiltz RL; Shih DS; Issel CJ; Montelaro RC
    J Virol; 1990 Jan; 64(1):86-95. PubMed ID: 2152836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.
    Nasioulas G; Zolotukhin AS; Tabernero C; Solomin L; Cunningham CP; Pavlakis GN; Felber BK
    J Virol; 1994 May; 68(5):2986-93. PubMed ID: 8151769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for Rev in the association of HIV-1 gag mRNA with cytoskeletal beta-actin and viral protein expression.
    Kimura T; Hashimoto I; Nishikawa M; Fujisawa JI
    Biochimie; 1996; 78(11-12):1075-80. PubMed ID: 9150887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological characterization of Rev variation in equine infectious anemia virus.
    Belshan M; Harris ME; Shoemaker AE; Hope TJ; Carpenter S
    J Virol; 1998 May; 72(5):4421-6. PubMed ID: 9557734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.
    Rosin-Arbesfeld R; Rivlin M; Noiman S; Mashiah P; Yaniv A; Miki T; Tronick SR; Gazit A
    J Virol; 1993 Sep; 67(9):5640-6. PubMed ID: 8394464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
    Stephens RM; Derse D; Rice NR
    J Virol; 1990 Aug; 64(8):3716-25. PubMed ID: 2164593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev.
    Tan W; Schalling M; Zhao C; Luukkonen M; Nilsson M; Fenyö EM; Pavlakis GN; Schwartz S
    J Virol; 1996 Jun; 70(6):3645-58. PubMed ID: 8648699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
    Schwartz S; Felber BK; Pavlakis GN
    J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.
    Lee JH; Murphy SC; Belshan M; Sparks WO; Wannemuehler Y; Liu S; Hope TJ; Dobbs D; Carpenter S
    J Virol; 2006 Apr; 80(8):3844-52. PubMed ID: 16571801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.